Funding Details
- Awarder
- Inbox
- Date Award
- May 17, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- Hillstar Bio is a leading biotechnology company focused on developing next-generation precision immunology therapies for autoimmune diseases. The company selectively targets and depletes pathogenic immune cells while sparing healthy ones, offering the potential for durable relief and immune reset for patients with autoimmune conditions.
- Market
- Autoimmune diseases
- Location
-
Boston,
MA,
USA
- Coinvestors
- Droia Ventures, Frazier Life Sciences, Novo Holdings A/S, LifeArc Ventures, Hummingbird Bioscience
Links